Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Science Applications Intl Raises FY2026 Adj EPS Guidance from $9.10-$9.30 to $9.40-$9.60; Lowers FY2026 Sales Guidance from $7.600B-$7.750B to $7.250B-$7.325B

Author: Benzinga Newsdesk | September 04, 2025 07:09am

Fiscal Year 2026 Guidance

The table below summarizes fiscal year 2026 guidance and represents the Company's views as of September 4, 2025.

 CURRENTPRIOR
 Fiscal YearFiscal Year
 2026 Guidance2026 Guidance
Revenue$7.250B - $7.325B$7.60B - $7.75B
Adjusted EBITDA$680M - $690M$715M - $735M
Adjusted EBITDA Margin %9.3% - 9.5%9.4% - 9.6%
Adjusted Diluted EPS$9.40 - $9.60$9.10 - $9.30
Free Cash Flow>$550M$510M - $530M

Posted In: SAIC


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist